PMID 25945462
Acknowledgements The authors wish to express their thanks for the excellent editorial support and suggestions provided by John Vahle, Bob Greenhill, John Foster, Chirukandath Gopinath, Rupert Kellner, Beth Mahler, Stuart Levin, Ken Schafer, Gordon Hard, Ian Pyrah, Charlotte Keenan, Maria-Luisa Phan Lung Whu, and Suzy Tirtodikromo
No published human oral bioavailability data exist for that peptide and formulation
Over time, Ipamorelin contributes to reduced fat mass, increased energy, and improved training capacity
Caution is required when prescribing phentermine and it is not recommended for patients with a history of CVD, hypertension, or a history of cardiac arrhythmias or seizures